Iron Triangle Partners LP
- SEC CIK
- 0001779763
- Latest filing
- Feb 17, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 26
- +3 vs. Q3 2023
- Portfolio value
- $772.9M
- +$88.7M (+13.0%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ACHCAcadia Healthcare Company, Inc. | COM | 791,993 | $61.6M | 8.0% | +26,789+3.5% | Added | History |
| UHSUniversal Health Services Inc | CL B | 321,886 | $49.1M | 6.3% | −179,914−35.9% | Reduced | History |
| ICLRIcon PLC | COM | 172,675 | $48.9M | 6.3% | +42,675+32.8% | Added | History |
| ELANElanco Animal Health Inc | COM | 3,000,000 | $44.7M | 5.8% | −412,350−12.1% | Reduced | History |
| IDXXIDEXX Laboratories Inc | COM | 76,025 | $42.2M | 5.5% | +76,025 | New | History |
| ISRGIntuitive Surgical Inc | COM NEW | 120,000 | $40.5M | 5.2% | −22,000−15.5% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 250,000 | $38.7M | 5.0% | 00.0% | Unchanged | History |
| MCKMcKesson Corp | Stock | 80,000 | $37.0M | 4.8% | +10,000+14.3% | Added | History |
| DXCMDexcom Inc | COM | 290,000 | $36.0M | 4.7% | −275,753−48.7% | Reduced | History |
| SGRYSurgery Partners, Inc. | Stock | 1,044,530 | $33.4M | 4.3% | +1,044,530 | New | History |
| BRKRBruker Corp | COM | 450,000 | $33.1M | 4.3% | +19,157+4.4% | Added | History |
| ILMNIllumina, Inc. | COM | 220,000 | $30.6M | 4.0% | +220,000 | New | History |
| INSPInspire Medical Systems, Inc. | COM | 150,000 | $30.5M | 3.9% | +150,000 | New | History |
| BKDBrookdale Senior Living Inc. | COM | 4,859,607 | $28.3M | 3.7% | +623,479+14.7% | Added | History |
| TXG10x Genomics, Inc. | CL A COM | 479,374 | $26.8M | 3.5% | −187,571−28.1% | Reduced | History |
| SNYSanofi | SPONSORED ADR | 500,000 | $24.9M | 3.2% | +500,000 | New | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 380,000 | $22.9M | 3.0% | −72,629−16.0% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 244,606 | $19.4M | 2.5% | −185,394−43.1% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 200,000 | $19.3M | 2.5% | +200,000 | New | History |
| OSCROscar Health, Inc. | CL A | 2,052,551 | $18.8M | 2.4% | +2,052,551 | New | History |
| PACBPacific Biosciences of California, Inc. | COM | 1,843,278 | $18.1M | 2.3% | +43,278+2.4% | Added | History |
| SDGRSchrodinger, Inc. | COM | 468,585 | $16.8M | 2.2% | +468,585 | New | History |
| RGENRepligen Corp | COM | 82,537 | $14.8M | 1.9% | +82,537 | New | History |
| MASS908 Devices Inc. | COM | 1,284,947 | $14.4M | 1.9% | +304,484+31.1% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,300,000 | $13.6M | 1.8% | +1,300,000 | New | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 331,238 | $8.58M | 1.1% | −238,888−41.9% | Reduced | History |
Sold out since Q3 2023 (7)
Positions held at the end of Q3 2023 that are gone from this filing.
| Security | Class | Shares in Q3 2023 | Value in Q3 2023 | % of portfolio in Q3 2023 | History |
|---|---|---|---|---|---|
| UTHRUnited Therapeutics Corp | COM | 210,635 | $47.6M | 7.0% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 880,000 | $33.5M | 4.9% | History |
| BSXBoston Scientific Corp | Stock | 400,000 | $21.1M | 3.1% | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 330,549 | $17.2M | 2.5% | History |
| EXASExact Sciences Corp | COM | 250,000 | $17.1M | 2.5% | History |
| Olink Hldg AB680710100 | SPONSORED ADS | 738,062 | $10.9M | 1.6% | – |
| SWTXSpringWorks Therapeutics, Inc. | COM | 150,211 | $3.47M | 0.5% | History |